Yi-Hsiang Liu Selected Research

Plectin

1/2018	Plectin deficiency in liver cancer cells promotes cell migration and sensitivity to sorafenib treatment.
10/2016	Cell Pleomorphism and Cytoskeleton Disorganization in Human Liver Cancer.
1/2015	Transient knockdown-mediated deficiency in plectin alters hepatocellular motility in association with activated FAK and Rac1-GTPase.
4/2011	Cytokeratin 18-mediated disorganization of intermediate filaments is induced by degradation of plectin in human liver cells.
3/2011	Plectin deficiency on cytoskeletal disorganization and transformation of human liver cells in vitro.
1/2011	Synemin down-regulation in human hepatocellular carcinoma does not destabilize cytoskeletons in vivo.
9/2008	Degradation of plectin with modulation of cytokeratin 18 in human liver cells during staurosporine-induced apoptosis.
4/2008	The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma.
1/2008	Pleomorphism of cancer cells with the expression of plectin and concept of filament bundles in human hepatocellular carcinoma.
1/2004	An early evaluation of malignant tendency with plectin expression in human colorectal adenoma and adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Hsiang Liu Research Topics

Disease

19	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2002
12	Neoplasms (Cancer) 01/2019 - 01/2002
7	Carcinogenesis 07/2017 - 01/2004
1	Infections 01/2018
1	Liver Neoplasms (Liver Cancer) 01/2018
1	Cholangiocarcinoma 01/2018
1	Fibrosarcoma 03/2015
1	Carcinoma (Carcinomatosis) 07/2008
1	Pain (Aches) 04/2006
1	Adenocarcinoma 01/2004
1	Adenoma (Adenomas) 01/2004

Drug/Important Bio-Agent (IBA)

10	PlectinIBA 01/2018 - 01/2004
5	Keratins (Keratin)IBA 01/2018 - 01/2002
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2002
4	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2018
4	Histones (Histone)IBA 07/2017 - 01/2002
4	Keratin-18 (Keratin 18)IBA 07/2017 - 07/2008
3	desmuslin (synemin)IBA 01/2011 - 01/2004
2	Cadherins (E-Cadherin)IBA 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2018
2	Histone Deacetylases (Histone Deacetylase)IBA 07/2017 - 03/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Histone Deacetylase 1IBA 03/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2015
1	AluminumIBA 04/2006
1	GalliumIBA 04/2006

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2019
2	Lasers (Laser) 04/2006 - 01/2004
2	Low-Level Light Therapy (LLLT) 04/2006 - 01/2004
1	Subcutaneous Injections 01/2019
1	Minimally Invasive Surgical Procedures 09/2012